Coherus to divest ophthalmology business for $170M : vimarsana.com

"Coherus BioSciences to divest ophthalmology franchise, Cimerli, to Sandoz for $170 million. Deal includes product inventory and access to commercial software

Related Keywords

Coherus Biosciences , , Meta Keywords Biopharmaceutical , Oherus Biosciences , Ivest , Phthalmology Franchise , Andoz , 70 Million , Imerli , Roduct Inventory ,